AZD1656 in Transplantation with Diabetes tO PromoTe Immune TOleraNce
Latest Information Update: 24 Jun 2024
At a glance
- Drugs AZD 1656 (Primary)
- Indications Renal transplant rejection; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms The ADOPTION Study
Most Recent Events
- 18 Jun 2024 Status changed from active, no longer recruiting to completed.
- 16 May 2023 Planned End Date changed from 1 May 2023 to 1 Aug 2023.
- 16 May 2023 Planned primary completion date changed from 1 Mar 2023 to 28 May 2023.